Addressing COVID-19 While Building Long-Term Capacity: Trends and Opportunities in Africa’s Growing Pharmaceutical Markets
The African pharmaceutical market’s estimated worth is between US $40 – $65 billion, but it remains largely untapped, with a heavy reliance on imports. According to Biodun Awosusi at Health Systems and Development Enterprise, the COVID-19 crisis shows the urgent need to unlock new partnerships and investments to accelerate the local production of medical supplies, medicines and vaccines, which could save lives and create jobs. He explores how Africa’s pharmaceutical sector is responding to the pandemic, and how it could be strengthened for the longer term.
Too Risky Not to Invest: Why Funding Latin America’s Healthcare Sector Should Be a Key Impact Investing Priority
Healthcare enterprises across Latin America are demonstrating both their impact in improving health outcomes, and their value as high-return investments. But as Andrea Bare at ThinkWell and Anna De La Cruz at ADLC Consulting point out, impact investors tend to view these organizations as too risky to finance. They explain why remaining on the sidelines represents another kind of risk: the risk of missing out on a sector full of profitable, impactful investment opportunities – particularly in women’s health.
Preparing for Life After COVID-19: How India’s Healthcare System Can Better Respond to Future Shocks
India’s public healthcare system was tested by the onset of COVID-19. Now that a vaccine promises to bring the end phase of the pandemic (gradually) into sight, Puneet Khanduja and Mitul Thapliyal at MicroSave (MSC) say it’s time to make the system more robust, to better absorb such shocks in the future. They share research that MSC conducted with low-income households in the states of Uttar Pradesh, Odisha and Bihar, and make recommendations to improve the healthcare system's preparedness for the next crisis.
Maker Spaces vs. COVID-19: How the Pandemic Is Bringing the Small Manufacturing Revolution to the Development Sector
When COVID-19 first struck, it soon became apparent that there wasn’t enough personal protective equipment (PPE) to go around. As Kuldeep Bandhu Aryal and Nishat Tasnim at BRAC point out, this has resulted in price gouging and acute scarcity, in Bangladesh and other developing (and developed) countries. They explore BRAC's innovative solution to this problem: collaborating with maker spaces and other small manufacturers to produce PPE locally and affordably.
Healthcare Cannot Exist Without Clean Water: Why WASH is the Foundation of an Effective Pandemic Response
Hospital beds and masks are often seen as the basic elements of defense against COVID-19. Yet for many developing countries, the pandemic has exposed even more fundamental disease prevention needs – namely, clean water and sanitation. Nafisa Jiwani at U.S. International Development Finance Corporation (DFC) discusses the vital role WASH plays in combating the pandemic, and how DFC is supporting water and sanitation efforts around the world.
The COVID-19 Pivot: How Five Nonprofits and Community-Based Enterprises Have Adapted in Response to the Pandemic
As COVID-19 has upended entire industries, businesses and non-profits everywhere have had to adapt to survive – sometimes shifting completely from their traditional services. June Sugiyama at the Vodafone Americas Foundation explores how five participants in the OpenIDEO COVID Business Pivot Challenge have quickly adjusted to provide innovative solutions to the crisis.
The Ripple Effects of Funding Global Health Innovations: How Philanthropic Capital and Impact Investing are Shaping Markets
The Saving Lives at Birth Grand Challenge for Development has leveraged nearly $80 million dollars in investment capital over the last decade to fund over 110 innovations targeting the maternal and neonatal health sector in emerging markets. Analysts at Duke University explore the program's impact in India and Kenya, two of the fastest-growing hubs of innovation in their respective regions.
Building Back Better: How the COVID-19 Crisis Could Lead to an Integration of Health Care and Finance
Since COVID-19 started, the health care world has been talking about finance, trying to lessen the economic damage of lockdowns. And the financial world has been talking about health, launching new products that address the challenges of the pandemic. Chris Wolff explores how the two industries can use their combined response to rebuild in a way that leaves the world in a better place than it was before.